Last reviewed · How we verify

NCT07016243: NODORSIFLEX

Correlation Between Deficits in Knee ROM Recovery and Difficulty in Dorsiflexing the Tibio-tarsal Joint in Patients Undergoing Total Knee Replacement Surgery.

Recruiting now Last updated 11 June 2025
What this trial tests

trial in Articulation Disorders in 197 participants. Currently enrolling.

Timeline
1 April 2025
Primary endpoint
1 April 2027
1 April 2027

Quick facts

Lead sponsorIstituto Ortopedico Rizzoli
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment197
Start date1 April 2025
Primary completion1 April 2027
Estimated completion1 April 2027
Sites1 location across Italy

Conditions studied

Sponsor

Istituto Ortopedico Rizzoli — full company profile →

Who can join

Adults 65 to 85, any sex, with Articulation Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To demonstrate that the deficit in dorsiflexion-tibia-talar joint range of motion can have an effect on the knee operated by arthroplasty by limiting full extension and, in general, the recovery of a full range of motion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Istituto Ortopedico Rizzoli trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07016243.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing